Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Depreciation and Depletion (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Depreciation and Depletion readings, the most recent being $327000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion fell 26.85% year-over-year to $327000.0, compared with a TTM value of $1.6 million through Dec 2025, down 13.3%, and an annual FY2025 reading of $1.6 million, down 13.3% over the prior year.
  • Depreciation and Depletion hit $327000.0 in Q4 2025 for Apellis Pharmaceuticals, down from $339000.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $476000.0 in Q4 2023, with the low at $282000.0 in Q1 2021.
  • Median Depreciation and Depletion over the past 5 years was $423000.0 (2023), compared with a mean of $403500.0.
  • The sharpest move saw Depreciation and Depletion surged 365.26% in 2021, then dropped 26.85% in 2025.
  • Year by year, Depreciation and Depletion stood at $373000.0 in 2021, then rose by 4.02% to $388000.0 in 2022, then rose by 22.68% to $476000.0 in 2023, then dropped by 6.09% to $447000.0 in 2024, then dropped by 26.85% to $327000.0 in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $327000.0, $339000.0, and $446000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.